StageAcquired | Acquired
Missing: JAC Computer Services's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: JAC Computer Services's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
JAC Computer Services Patents
JAC Computer Services has filed 4 patents.
The 3 most popular patent topics include:
- Bulk material handling
- Freight rolling stock
- Partner dance technique
Bulk material handling, Freight rolling stock, Tires, Rowing racing boats, Partner dance technique
Bulk material handling, Freight rolling stock, Tires, Rowing racing boats, Partner dance technique
Latest JAC Computer Services News
Apr 9, 2021
Mediware Announces Agreement to Acquire Chemotherapy Management Software Home > Mediware Announces Agreement to Acquire Chemotherapy Management Software Mediware Announces Agreement to Acquire Chemotherapy Management Software Acquisition expands company’s role in effectively managing patient-specific cancer treatments in key markets worldwide. LENEXA, KS March 15, 2012 – Mediware Information Systems, Inc. today announced that it has signed an agreement with Cobbler ICT Services BV to acquire the assets associated with the Cyto Management System (CMS), a comprehensive chemotherapy management software solution currently deployed in Holland and Belgium. The CMS software was designed specifically to track patients, manage highly individualized medication-based treatment plans, help control costs, and report outcomes associated with cancer therapies performed in hospitals and oncology centers. The software utilizes a multilingual language platform that makes the product easy to configure for new international markets. The transaction is expected to cost Mediware €1.7 million ($2.2 million USD) and close in mid-April. Mediware will continue marketing the software through existing European distribution agreements under Mediware’s international brand and open a regional office in Holland to manage European sales and services. The software will also be made available immediately to the UK and Irish markets to capitalize on the dominant position of the company’s UK-based JAC medication management product suite, which is used by more than 50 percent of UK hospitals. Additional geographic expansion will occur as opportunities arise. Commenting on the pending acquisition, Mediware’s president and chief executive officer, Thomas Mann said: “Oncology is one of the fastest growing areas of healthcare. There are more than 11 million new cancer cases reported every year, a number that could increase to 16 million by 2020. As a result, there have been huge investments in new treatment technologies and pharmaceuticals. Cancer drugs alone have seen a four-fold increase in sales over 10 years to more than $19 billion in 2008. Yet, despite this intense global investment, care providers are still underserved by software solutions that do not effectively manage the data, process and reporting requirements of these complex personalized treatment plans. “With the cost of care increasing dramatically, we believe there is a critical need for a system that provides precise therapy management for the patient, while also monitoring and reporting those treatments, their outcomes and costs. The acquisition of the CMS software and intellectual property is strategic, provides a good value for Mediware and launches us in a new area of care. With our experience in medication management, FDA regulations and complex information management, I believe Mediware has the experience to become a leader in this pivotal and rapidly growing area of healthcare technology.” Seen as an area of revenue growth that is both rapid and long term, Mediware has been evaluating oncology treatment management solutions in the US and Europe for more than 18 months. Based on this market analysis, the CMS software solution provided the company the functionality and technology platform to quickly expand in multiple geographic markets. “Driving the high growth potential of this global market is the recognition that highly personalized cancer care is increasingly important to patient survival rates,” continued Mr. Mann. “But to be optimally effective these precision treatment regimens require robust and highly specialized information systems capable of coordinating therapies and tracking outcomes while managing costs. “The CMS software is well positioned to support these goals. It has rich clinical features and powerful integration capabilities that enable its use with our existing products as well as the hospital’s core electronic health record. It also has a robust multi-lingual platform that provides the solution with multi-national appeal. This should make it an efficient contributor to our continued international growth.” The CMS acquisition provides Mediware the opportunity to immediately enhance its solution offerings in JAC’s current markets and broaden the company’s global structure. With the addition of CMS, JAC enhances its position as the leading medication management technology vendor in the UK with proven software solutions for pharmacy management, e-prescribing, medication administration and chemotherapy management. “Customers in the UK and Ireland are looking increasingly for e-prescribing and medication management suppliers to offer a broader more complete solution. The addition of CMS to our UK portfolio positions JAC uniquely in the market place to deliver a comprehensive medication management solution,” said Robert Tysall- Blay, managing director of Mediware’s international operations and chief executive of JAC Computer Services Ltd, in the UK. Mediware will be demonstrating the CMS solution for European prospects during the European Association of Hospital Pharmacists (EAHP) conference and exposition, which will be held in Milan March 21-23. About Mediware Mediware delivers interoperable best-of-breed software systems that improve efficiencies and address safety concerns, enabling healthcare organizations to improve care processes while decreasing costs. Core Mediware solutions include blood management technologies for hospitals and blood centers; medication management solutions for hospitals, behavioral health facilities, infusion and specialty pharmacy providers; and business intelligence-based performance management solutions for clinical, regulatory and financial aspects of the broader healthcare market. For more information about Mediware products and services, visit our website at https://www.mediware.com/ . About JAC JAC is the UK’s leading medicine management systems specialist, with the largest installed base of Electronic Prescribing and Medicines Administration systems in UK hospitals. With over 20 years experience within medicines management, JAC provides pharmacy stock control, e-prescribing and medicines administration as a single integrated solution along with associated services and third-party interfaces. JAC’s systems are used in more than half of all NHS trusts in England as well as sites in Scotland, Wales, Northern Ireland, Ireland and South Africa. About the Cyto Management System The CMS software is a comprehensive ‘closed loop’ solution for managing chemotherapy treatments that is focused on reducing errors, streamlining patient management and optimizing efficiency through the care treatment process. Consisting of five main components, CMS manages the prescription of chemotherapy for the physician, the planning of the chemotherapy for the patient, the planning for the preparation of the chemo therapy, the preparation of cytotoxic drugs and all the other sterile preparations. CMS is designed to be highly interoperable and includes multi-lingual capabilities to allow the software to be easily configured for international distribution. ### Certain statements in this press release may constitute “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the “Act”) and are intended to be covered by the safe harbor created thereby. Such forward-looking statements are not necessarily based on historical facts and involve known and unknown risks, uncertainties and other factors which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward looking statements. These risk and uncertainties include but are not limited to those disclosed in the Company’s Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company does not intend to, and undertakes no obligation to, update forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial condition or business over time. The Company regularly posts important information to the investor relations section of its website. Save time. Save money. Improve efficiency. Phone: (913) 307-1000 John Hutchinson Senior Vice President, Client Experience As senior vice president of client experience, John Hutchinson is responsible for defining, developing, and executing strategic plans to achieve a superior client experience. With more than 15 years of health care experience, John has a proven track record of leading teams with a focus on delighting clients and optimizing their success. Prior to WellSky, John served as vice president of the clinical and technology strategic business unit at Cerner where he was responsible for developing an organization mindset and operating rhythm that balanced solution expertise with a client-centric relationship model. John’s experience also includes various financial and operational roles at Sprint. John earned his MBA and bachelor’s from the University of Kansas. CLOSE Senior Vice President, Operations As senior vice president of operations, Amy Shellhart enforces a clear mission and framework to WellSky’s innovation efforts. Drawing on 25 years of healthcare industry experience, Amy is responsible for optimizing the effectiveness of the engineering and innovation teams in our ongoing efforts to improve client experience. Prior to WellSky, Amy served as vice president of product management at Change Healthcare. Amy’s experience also includes leading the charge in establishing the MassineBoecker, Inc. population health management footprint in the U.S. and 15 years at Healthways providing strategic direction and operational insight before transitioning to vice president of product development and management. Amy earned her MBA and bachelor’s degree from Southwest Baptist University. CLOSE Chief Operating Officer Steve Morgan serves as chief operating officer for Mediware and is responsible for setting direction and executing against the company’s strategic objectives and priorities. With 16 years of industry experience, a passion for company culture, and an emphasis on the client experience, Steve leads Mediware’s diverse teams focused on optimizing client workflows, efficiencies, and outcomes. Prior to joining Mediware in June 2018, Steve served as COO for OptumInsight, a division of Optum, which is the health services platform of UnitedHealth Group. Steve was broadly responsible for the company’s annual operating plan with a focus on employee engagement, client management, growth, and innovation. He was fundamental to the growth and strategic scalability of OptumInsight on an organic basis and through the completion of several critical acquisitions that were integrated into the company. Steve holds a bachelor’s degree in accounting and business administration from the University of Kansas. CLOSE Chief Executive Officer Bill Miller is the CEO of Mediware and a recognized leader in the healthcare industry. He has a rich background that includes a more than 20 year history of bringing groundbreaking growth strategies and technological innovation to the healthcare marketplace and a proven track record of launching and leading highly successful healthcare IT companies. Prior to joining Mediware in July 2017, Bill was the CEO of OptumInsight, a division of Optum, which is the health services platform of UnitedHealth Group. Under Bill’s leadership, OptumInsight experienced unprecedented revenue growth, expanded margins, and claimed a transformative position in the health services market. He led the evolution of Optum into the leader in health care analytics and launched several tech-enabled business platforms. Prior to OptumInsight, Bill served as senior vice president of technologies at Cerner Corporation, where he had global responsibility for the company’s managed services, outsourcing, and technology services business units. A graduate of the University of Kansas, Bill holds a bachelor’s degree in economics and a master’s degree in urban planning and public policy. CLOSE President, Home Care Chris Hester founded Kinnser Software in 2003, when he developed an innovative web-based application for home health agencies. He served as the company’s president for 14 years of rapid growth, which saw Kinnser become the most widely used EMR in home health and expand into new markets, including hospice and private duty home care. Kinnser Software was acquired by Mediware in June 2017. Today, Chris serves as president of Mediware’s home care division, which includes applications for home care, home health, and rehabilitation. CLOSE President, Community Care Rob Weber serves as president of Mediware’s diverse community care division, overseeing applications for behavioral health, homeless management, long-term services and supports, medication management, and blood management. Rob has held this position since 2017, and he previously also managed many of Mediware’s other clinical applications, including blood services and medication management. Rob joined Mediware in January 2004, originally serving as executive vice president and general counsel, and he continues to serve as the company’s general counsel for legal and regulatory matters. CLOSE Chief Financial Officer Robert “Bob” Watkins started at Mediware as corporate controller in 2008. In 2011, he was promoted to vice president and corporate controller and to CFO in 2012. Prior to joining Mediware, Bob held a number of financial management positions, including serving as corporate controller for Titan Machinery (TITN), a $1 billion provider of agricultural and construction equipment. His prior experience also includes a corporate controller position at AFS Financial, where he also served as chief financial officer. Bob is a current member of the AICPA and Financial Executives International. CLOSE Chief Technology Officer In his role as chief technology officer, Joel Dolisy manages both product development and information technology for Mediware. Before joining Mediware as CTO, Joel was CTO of Kinnser Software, where he led the company’s engineering and product organizations. Before Kinnser, Joel was SVP, CTO, and CIO for SolarWinds, a leading provider of IT management software. With more than 20 years of experience in product strategy and software engineering, Joel is a leader in developing and delivering commercial software products to market. CLOSE Executive Vice President, Growth As executive vice president of growth, Chris Stansbury works with all sales teams within Mediware to create and standardize best practices for selling, interacting, contracting, and negotiating with clients. With over 25 years of health care IT services sales leadership, Chris has experience in all aspects of health care, including the provider side when he was at Cerner, the payer side when he was at TriZetto, and the Wellness side as he most recently was a vice president at Welltok. CLOSE Chief Marketing Officer As chief marketing officer, Shoma Sarkar Thomas oversees the marketing strategy for all WellSky products and is responsible for building the WellSky brand, which includes public relations, communications, and all strategic marketing activities. Previously, Shoma served as vice president of marketing for Kinnser Software, where she led marketing and strategic growth initiatives. She holds a bachelor’s degree in economics and international relations from the University of Virginia. CLOSE SVP of Human and Social Services Stephen (Steve) Greenberg is responsible for Mediware’s Homeless & Community, Behavioral Health and LTSS businesses. Prior to joining Mediware, Steve was President of DecisionHealth, LLC for six years, after which time he successfully helped execute the sale of this revenue cycle management decision-support company. Before that, he worked at OptumInsight for 12 years as a senior leader of many of its provider software and service solutions and, in his last role as SVP, Government Solutions, built a prospective and retrospective fraud, waste and abuse detection capability for UnitedHealthcare’s Medicare and Medicaid businesses. CLOSE Senior Vice President, Human Capital Dana Streck leads Mediware’s human capital organization. Before joining Mediware, Dana was senior director of workforce transitions for Cerner Corporation, where she welcomed and transitioned new team members into Cerner through client partnerships and acquisitions. With more than 15 years of experience in human resources, Dana has successfully partnered with business leaders to drive workforce initiatives that benefit both companies and clients, while simultaneously creating environments that support growth and innovation. CLOSE VP, Corporate Development As vice president of corporate development for Mediware, Jason Baker is responsible for acquisitions, partnerships, and new market strategies. Prior to joining Mediware, he was a managing director for Alpine Healthcare Advisors and Healthcare Growth Partners, both of which provide investment banking services in healthcare technology and services. Jason also served as head corporate development executive for Cerner Corporation. He holds an MBA from the University of Chicago Graduate School of Business and a bachelor’s degree in business administration from the University of Missouri. CLOSE Vice President, Applied Insights As vice president of analytics, Wes Little leads Mediware’s unified analytics strategy to deliver data-driven insights and innovative solutions. He previously served as director of product management for Kinnser Software, where he oversaw rapid product innovation for the company’s home health electronic medical record software. Wes holds a Master of Business Administration from the University of Texas at Austin’s McCombs School of Business and a bachelor’s degree in economics from Washington and Lee University. CLOSE
JAC Computer Services Frequently Asked Questions (FAQ)
Where is JAC Computer Services's headquarters?
JAC Computer Services's headquarters is located at 1 Aurum Court, Basildon.
What is JAC Computer Services's latest funding round?
JAC Computer Services's latest funding round is Acquired.
Who are the investors of JAC Computer Services?
Investors of JAC Computer Services include WellSky.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.